Job Seekers, Welcome to LOA Careers
Search Filters
Use this area to filter your search results. Each filter option allows for multiple selections.
NEW! NEW!
NEW! NEW!
Zucker School of Medicine at Hofstra/Northwell
New York, New York
Appalachian State University - Department of Chemistry and Fermentation Sciences
Boone, North Carolina
Baylor College of Medicine
Houston, Texas
Wake Forest University
Winston Salem, North Carolina
USDA-ARS ORISE
El Reno, Oklahoma
Howard Hughes Medical Institute
Austin, Texas
National Park Service
Twentynine palm, California
Vanderbilt University
Nashville, Tennessee
USDA-Agricultural Research Service / ORISE
Albany, California
University of Pennsylvania
Philadelphia, Pennsylvania
Department of Biology, University of Saskatchewan
Saskatoon, Saskatchewan, Canada
Max Planck Institute for Heart and Lung Research
Bad Nauheim, Germany
Loading... Please wait.
About Oliver Lab -- Emory University School of Medicine
Dr. Oliver has pursued studies of cystic fibrosis (CF) pathogenesis since 2009. She began her scientific career as a master’s student at Auburn University, where she characterized adaptive metabolic strategies by which Pseudomonas aeruginosa chronically establishes itself in the lungs of individuals with CF. After graduating with an M.S. in Microbiology, she worked one year as Lead Instructor for the “Genetics and Evolution” course at the University of Alabama in Huntsville. In 2012, Dr. Oliver enrolled in the Genetics graduate program at the University of Alabama at Birmingham to study CF disease mechanism. Her dissertation project utilized high-throughput yeast phenomics to identify novel genetic modifiers of the most common CF-causing variant (F508del-CFTR) and elucidated, for the first time, effects of ribosomal perturbation on CFTR synthesis, trafficking, and function. Dr. Oliver began postdoctoral training at Emory University in 2017 and continued to work towards a career in basic and translational science. Her studies concentrated on evaluating changes in translation kinetics – both in vitro and in vivo – following suppression of specific ribosomal proteins.
In 2021, Dr. ...Oliver was promoted to Assistant Professor of Pediatrics at Emory. Her current research program employs interdisciplinary approaches in molecular genetics, RNA biology, biochemistry, cellular physiology, and functional genomics to investigate impact of translational speed, ribosome fidelity, and mRNA surveillance on protein synthesis in the context of CF. Particular emphasis is placed on premature termination codons (PTCs) and other rare defects that occur in the CFTR gene, specifically evaluating underlying mechanism(s) responsible for genotype-phenotype correlation, pharmacologic responsiveness, and heterogeneity of patient outcomes. Dr. Oliver’s scientific objectives also include better delineation of genetic factors that influence severity of refractory CFTR variants, including attention to mutations that occur in non-Caucasian people with the disease. Her overarching goals are to provide new insights relevant to CF clinical intervention and extend research findings to other pediatric conditions with similar etiology. Dr. Oliver presently serves on the national CF Foundation (CFF) Clinical Guidelines Steering Committee and CFF Guidelines Committee for CF Related Metabolic Disorder and CF Screen Positive Inconclusive Disorder, as well as the CF Newborn Screening Committee within the Georgia Department of Public Health.
Show more
Show less
https://careers.atloa.org/jobs/16386507/postdoctoral-fellow
Loading. Please wait.